Janet Stewart is a life sciences writer and editor, who completed both PhD course work and oral examinations in the Department of Microbiology and Immunology at McGill University, and holds an M.Sc. in Virology and Immunology.
Takeda has granted commercialization rights to Aska Pharmaceuticals in Japan for the investigative therapy relugolix for the treatment of uterine fibroids, and development and ... Read more
The properties of AbbVie‘s elagolix (ABT-620), an investigative therapy for treating endometriosis and uterine fibroids, were found to be similar in ... Read more